Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and Related Compounds-Reference-Cited by-同舟云学术

Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and Related Compounds

Published:1996-01-01 Issue:18 Volume:39 Page:3547-3555
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ogawa Hidenori¹,Yamashita Hiroshi¹,Kondo Kazumi¹,Yamamura Yoshitaka¹,Miyamoto Hisashi¹,Kan Keizo¹,Kitano Kazuyoshi¹,Tanaka Michinori¹,Nakaya Kenji¹,Nakamura Shigeki¹,Mori Toyoki¹,Tominaga Michiaki¹,Yabuuchi Youichi¹

Affiliation:

1. Second Institute of New Drug Research, Otsuka Pharmaceutical Co., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-01, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm960133o

Reference27 articles.

1. Design, Synthesis and Some uses of Receptor-Specific Agonists and Antagonists of Vasopressin and Oxytocin

2. Design of cyclic and linear peptide antagonists of vasopressin and oxytocin: current status and future directions

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis of tolvaptan binding to the vasopressin V2 receptor;Acta Pharmacologica Sinica;2024-06-20

2. Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery;Medicinal Research Reviews;2024-03-21

3. Controllable Synthesis of N- and O-Containing Heterocycles via Formal [3 + 2] and [5 + 2] Cyclizations;Organic Letters;2023-12-29

4. Construction of diazepine-containing spiroindolines via annulation reaction of α-halogenated N-acylhydrazones and isatin-derived MBH carbonates;Beilstein Journal of Organic Chemistry;2023-12-18

5. Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V₂ Receptor in In Vitro, Ex Vivo, and In Vivo Models of ADPKD;Journal of Medicinal Chemistry;2022-12-23